← FDA DRUG APPROVALS

FDA NDA · NDA018863

BETATREX

Sponsor: SAVAGE LABS

APPLICATION
NDA018863
TYPE
NDA
ORIGINAL APPROVAL
1983-08-31
LATEST ACTION
1999-03-04
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

BETATREXDiscontinued
BETAMETHASONE VALERATE EQ 0.1% BASE · OINTMENT · TOPICAL

Approval history

1999-03-04Labeling · Supplement 10AP
1996-03-07Manufacturing (CMC) · Supplement 9AP
1988-11-07Labeling · Supplement 8AP
1988-10-24Manufacturing (CMC) · Supplement 7AP
1988-10-24Manufacturing (CMC) · Supplement 6AP
1987-04-23Manufacturing (CMC) · Supplement 3AP
1987-04-23Manufacturing (CMC) · Supplement 4AP
1986-01-24Manufacturing (CMC) · Supplement 2AP
1983-08-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →